Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers & Shakers
  • Penny Stocks

Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off

By Ragothaman Srinivasan
August 22, 11:17 AM
Cue Biopharma (NASDAQ: CUE) has dosed the first patient in a Phase 1 dose escalation study evaluating CUE-102 for the treatment of patients with Wilms' Tumor 1 (WT1)-positive recurrent/metastatic cancers.

CUE

Read More
1 minute read
  • FDA
  • General
  • Hot
  • News
  • Politics

Anthony Fauci, Says Will Be Stepping Down From Positions Of Director Of NIAID And Chief Of The NIAID Laboratory Of Immunoregulation; Says Will Be Stepping Down From Position Of Chief Medical Advisor To President Joe Biden; Will Be Leaving In Dec.

By Benzinga Newsdesk
August 22, 11:03 AM
-Reuters

SPY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks

Minerva Seeks FDA Approval For Schizophrenia Candidate

By Ragothaman Srinivasan
August 22, 10:51 AM
Minerva Neurosciences (NASDAQ: NERV) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for roluperidone in the treatment of negative symptoms for patients with schizophrenia.

NERV

Read More
1 minute read
  • Education
  • General
  • Top Stories

Cadillac Was Founded 120 Years Ago Today

By Wayne Duggan
August 22, 10:32 AM
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened? On this day in 1902, the Cadillac Motor Company was founded. Where The Market Was The Dow Jones Industrial Average trade at around 64.40 and the S&P 500 traded at 8.85.

F

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers & Shakers
  • Small Cap

Belite Bio Shares Gain On Initiation Of Late-Stage Retinal Disease Study

By Ragothaman Srinivasan
August 22, 10:23 AM
Belite Bio (NASDAQ: BLTE) has initiated enrollment for the U.S. Phase 3 clinical trial of its lead asset LBS-008 in patients with Stargardt Disease (STGD1), a progressively blinding disease with no approved treatment.

BLTE

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

UK Says Monkeypox Vaccines To Be Piloted In Smaller But ‘Equally Effective’ Doses

By Benzinga Newsdesk
August 22, 10:19 AM
-Reuters

AEMD

Read More
3 minute read
  • Entertainment
  • General
  • Movers
  • News
  • Top Stories
  • Trading Ideas

AMC Is Bringing ‘Godzilla Vs. Kong’ To Theaters For Free To Coincide With APE Share Launch: ‘I Prefer Apes Over Lizards’

By Chris Katje
August 22, 10:16 AM
A monster movie is coming back to movie theaters for free for some people. Here’s who gets to see the movie for free and why the movie is coming back to theaters.

$APE

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Government
  • Health Care
  • Large Cap
  • News

Moderna to Supply 12M Doses of Omicron-Adapted COVID-19 Booster To Canada

By Vandana Singh
August 22, 10:04 AM
Moderna Inc (NASDAQ:MRNA) will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus…

MRNA

Read More
1 minute read
  • Earnings
  • General
  • Health Care
  • M&A
  • News

Teleflex Beefs Up Its Bariatric Surgery Portfolio With This $170M Acquisition

By Vandana Singh
August 22, 9:54 AM
Teleflex Incorporated (NYSE:TFX) has agreed to acquire Standard Bariatrics Inc for an upfront cash payment of $170 million and additional consideration of…

TFX

Read More
1 minute read
  • Commodities
  • General
  • Markets
  • News
  • Politics

‘Household energy bills ‘to hit £5,300-a-year by April’: Latest price cap prediction suggests price of gas and electricity will nearly DOUBLE from October to April – amid warnings inflation will hit 18% in new year’ -Daily Mail Report

By Benzinga Newsdesk
August 22, 9:49 AM
https://www.dailymail.co.uk/news/article-11134585/Household-energy-bills-hit-5-300-year-April.html?ito=social-twitter_mailonline

EWU

Posts pagination

Previous 1 … 2,210 2,211 2,212 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service